CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 207 filers reported holding CARDLYTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,998,473 | +232.8% | 424,150 | +27.5% | 0.01% | +150.0% |
| Q2 2023 | $2,102,982 | +146.5% | 332,750 | +32.4% | 0.00% | +100.0% |
| Q1 2023 | $853,302 | -34.7% | 251,341 | +11.2% | 0.00% | 0.0% |
| Q4 2022 | $1,306,361 | -49.5% | 226,014 | -17.9% | 0.00% | -50.0% |
| Q3 2022 | $2,587,000 | -39.9% | 275,176 | +42.5% | 0.00% | -50.0% |
| Q2 2022 | $4,307,000 | -42.9% | 193,058 | +40.8% | 0.00% | -33.3% |
| Q1 2022 | $7,538,000 | -11.2% | 137,106 | +6.7% | 0.01% | -14.3% |
| Q4 2021 | $8,492,000 | -17.9% | 128,493 | +4.2% | 0.01% | -30.0% |
| Q3 2021 | $10,348,000 | -15.6% | 123,273 | +27.6% | 0.01% | -16.7% |
| Q2 2021 | $12,265,000 | +58.9% | 96,632 | +37.4% | 0.01% | +33.3% |
| Q1 2021 | $7,717,000 | -20.6% | 70,346 | +3.4% | 0.01% | -30.8% |
| Q4 2020 | $9,715,000 | +1903.1% | 68,045 | +880.9% | 0.01% | +1200.0% |
| Q2 2020 | $485,000 | – | 6,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |